Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

CytomX Therapeutics Announces Initial Phase 1a Dose Escalation Data For Monotherapy CX-904; Demonstrated Favorable Safety Profile, Says 2 Of 6 Patients Confirmed Partial Response And All 6 Patients With Disease Control

Author: Benzinga Newsdesk | May 08, 2024 04:50pm

Posted In: CTMX